Fas (Apo-1/CD95) is a cell-surface receptor involved in cell death signaling through binding of Fas ligand. Mutation of Fas gene in lymphoid cells results in accumulation of these cells, which might thus contribute to lymphomagenesis. We examined the open reading frame of Fas cDNA in 14 cases of nasal NK/T-cell lymphoma. Mutations of Fas gene were detected in seven (50%) of 14 cases which comprised four frameshift, two missense, and one silent mutations. Frameshift mutations were caused by insertion of 1 bp (A) at nucleotide 1095 in two cases and by deletion of 1 bp at nucleotide 597 and at 704, respectively, in one each. Mouse T-cell lymphoma cells transfected with two missense mutated genes and frameshift mutations caused by insertion of 1 bp (A) at nucleotide 1095 were resistant to apoptosis induced by the anti-Fas antibody. These findings suggested that accumulation of lymphoid cells with Fas mutations provides a basis for the development of nasal NK/T-cell lymphoma. Oncogene (2002) 21, 4702 -4705. doi:10.1038/sj.onc. 1205571
Keywords: nasal NK/T cell lymphoma; Fas; apoptosis; mutation Nasal NK/T-cell lymphoma (NKTCL) is a clinical condition of lethal midline granuloma that shows necrotic, granulomatous lesions in the upper respiratory tract, especially in the nasal cavity (Jaffe et al., 1996) . The disease is more frequent in Asian countries than in Western countries (Aozasa et al., 1992) , and was demonstrated to be highly associated with Epstein-Barr virus (EBV) infection (Harabuchi et al., 1990) . Recently, mutations of c-kit proto-oncogene and tumor suppressor p53 gene were reported. However, understanding of the molecular mechanism of nasal NKTCL remained inadequate.
Fas (Apo-1/CD95) is a 45 kDa membrane protein belonging to the tumor necrosis factor receptor family, and mediates programmed cell death (apoptosis) through binding of Fas ligand (FasL) (Suda et al., 1993) . Fas consists of 325 amino acids with a single transmembrane domain, including signal peptide. The 80-amino acid portion in the cytoplasm, designated as a death-signaling domain, is essential for the apoptotic signal transduction (Itoh and Nagata, 1993) . Fas gene mutations have been reported both in the lymphoid lineage and epithelial malignancies; about 10% of cases with multiple myeloma (Landowski et al., 1997) , 11% with sporadic non-Hodgkin's lymphoma (Gronbaek et al., 1998) , 20% with Hodgkin and Reed-Sternberg cells in classical Hodgkin's disease (Muschen et al., 2000) , 11.6% with gastric cancer (Park et al., 2001), 7.7 -20 .3% with lung cancer (Lee et al., 1999b; Boldrini et al., 2001) ; and 28% with urinary bladder cancer (Lee et al., 1999a) .
Recent study showed that the nasal NKTCL frequently express FasL together with Fas (Ng et al., 1999) , which might be responsible for local tissue damage resulting in necrosis of tissue around tumors and contribute to the clinical aggressiveness of these tumors. Alternatively, some mechanisms for resistance to Fas/FasL-induced apoptosis might work in the development of nasal NKTCL, thus Fas gene mutations could be one of the mechanisms for development of nasal NKTCL. Therefore, we examined the open reading frame of Fas cDNA in 14 cases of nasal NKTCL. Patients were admitted to the hospitals during the period from 1996 to 2000. Age of patients ranged from 36 to 82 years (median, 63) with a male to female ratio of 11 : 3. All patients presented with the necrotic and granulomatous lesions in the upper respiratory tract, mostly nasal cavity, which were biopsied for the histologic diagnosis before treatment. Histologic sections were reviewed by two of the authors (T Takakuwa, K Aozasa) for diagnosis. Varying degrees of necrosis were found in the upper respiratory tract lesions. Diffuse proliferation of large atypical cells with mono-or multinucleus was observed accompanying with varying numbers of lymphocytes, plasma cells, and macrophages, giving a polymorphous appearance. An angiocentric pattern of proliferation was occasionally observed. Immunohistochemically, tumor cells were CD20
7 , TIA-1 + , CD16 + , CD56 + , CD3 + , or CD43 + . These histological and immunohistochemical findings were in agreement with those in the nasal NKTCL (Jaffe et al., 1996) . Denaturing gradient gel electrophoresis analysis was employed to examine the rearrangement of the T-cell receptor g chain genes in six of the present cases with proven clonal proliferation of EBV genome-containing cells, as previously described (Ohsawa et al., 1999) . All six cases did not show clonally rearranged bands, indicating the absence of T-cell clones in these cases. RNA in situ hybridization using EBER-1 probe, which was performed as previously described (Weiss et al., 1992) , revealed the positive signals in the nucleus of the proliferating cells in all cases, indicating the presence of EBV.
Mutations of Fas gene were detected in seven (50%) of 14 cases of nasal NKTCL. Whether the detected Fas mutations were heterozygous or homozygous could not be determined because nasal lesions showed a polymorphous pattern of proliferation containing the tumor cells and inflammatory reactive cells. The Fas mutations comprised of four frameshift, two missense, and one silent mutation ( Figure 1 ). All but one of the silent mutations affected the death domain which is essential for apoptotic signal transduction. Previous studies on the lymphoid lineage (Landowski et al., 1997; Gronbaek et al., 1998; Muschen et al., 2000; Takakuwa et al., 2001 ) and epithelial malignancies (Lee et al., 1999a,b; Boldrini et al., 2001; Park et al., 2001) showed that the majority of Fas mutations observd in these diseases were also located in the death domain. Fas gene has a 6-(A) tract from nucleotide 1088 to nucleotide 1094. Two cases showed insertion of 1 bp (A) at nucleotide 1095, which resulted in generation of a frameshift. As a result, stop codon was introduced at residue 304. Another case showed deletion of 1 bp (T) in a 7-(T) tract from nucleotide 591 to 597 of Fas coding sequence. The remaining case had deletion of 1 bp (C) at nucleotide 704. These two mutations generated frameshifts, and resulted in stop codon at residue 170. Because these mutants affect transmembrane domain, the abnormal protein might not be expressed on the cell surface.
Three point mutations were detected in exon 9, and two of these were missense ones, which caused substitutions of nonconserved amino acid. These mutations within the death domain affected codons 246 (ATC?GTC; Ile?Val) and 287 (CTT?CCT; Leu?Pro) (GeneBank accession number M67454) (Itoh et al., 1991) .
Anti-human Fas antibody kills mouse T-cell lymphoma cells WR19L which express human Fas cDNA. This indicates that the Fas receptor mediates an apoptotic signal into cells. To confirm whether the mutations detected in the present cases abolish the apoptotic signal transduction of the Fas receptor, these Fas gene mutants were prepared and introduced into WR19L cells. Northern blot analysis demonstrated that Fas gene were expressed successfully (Figure 2a) . However, fluorescence-activated cell sorting (FACS) analysis with use of anti-Fas monoclonal antibody detected the expression of the human Fas receptor on the cell surface only when Fas gene mutants containing a conserved transmembrane domain (A978G, 1095 ins A, T1102C) were introduced (Figure 2b) .
The ability of the mutated Fas on the cell surface to transduce the apoptotic signal was then examined in the established transformants. To exclude the clonal variations of Fas receptor expression, two independent clones were chosen for each mutant. Clones expressing the wild type Fas receptor were killed by Fas antibody. On the other hand, clones expressing the Fas receptor with any mutations (A978G, 1095 ins A, T1102C) were resistant to apoptosis induced by the anti-FAS antibody (Figure 3) .
The NKTCL cells were reported to express Fas and FasL (Ng et al., 1999) . Because cross-linking of FasL with Fas induces apoptosis, interaction of NKTCL cells from each other should result in apoptosis of the nasal NKTCL cells, thus prohibiting development of the disease. Therefore, some mechanism for resistance of nasal NKTCL cells to Fas/FasL-induced apoptosis might work for tumor development. Mutations of Fas gene could be one of the mechanisms. Mutations of Fas gene were detected in seven of 14 (50%) present cases of nasal NKTCL. Relatively high frequency of Fas gene mutations was reported in cases with thyroid lymphoma (65.4%) (Takakuwa et al., 2001 ) and other kinds of malignant lymphoma of mucosa-associated lymphoid tissue (MALT) type (Seeberger et al., 2001) , although this remains a subject of controversy (Bertoni et al., 2000) . It is well-recognized that follicular gastritis caused by the infection of Helicobacter pylori Figure 1 Summary of the Fas gene mutations found in patients with nasal NKTCL. Total RNA was extracted using TRIzol reagent (Gibco BRL, NY, USA) and was reverse-transcribed by random hexamer priming. The Fas open reading frame was amplified using primer pairs of 5'-CACTTCGGAGGATTGCTCAA-CA-3' and 5'-TATGTTGGCTCTTC-AGCGCTA-3' and then cloned in the pCR2.1-TOPO (Invitrogen, CA, USA). For the control of potential PCR error, eight to 12 clones derived from two different PCR reactions were sequenced, respectively. When common mutations were found in two PCR, we regarded them as definite mutations. The shaded rectangles at the COOH-terminus of the protein represents the small peptide added because of the frameshift in the gene encoding FAS. TM: transmembrane domain, Mr: molecular weight Fas gene mutations in nasal lymphoma T Takakuwa et al provide a basis for development of gastric lymphoma of MALT type (Wotherspoon et al., 1993; Enno et al., 1995) , and chronic lymphocytic thyroiditis for the thyroid lymphoma (Kato et al., 1985; Holm et al., 1985) . Coexistence of inflammatory cells are common findings in these lymphomas, which is also constantly found in nasal NKTCL (Jaffe et al., 1996) . Taken together, resistance to apoptosis induced by mutations of Fas gene might be involved in the development of lymphomas accompanying with inflammatory cells.
One base insertion within a 6-(A) tract from nucleotide 1088 to 1094 was found in two cases and one base deletion within a 7-(T) tract from nucleotide 591 to 597 in one case. The insertion of 1 bp (A) at nucleotide 1095 is also found in lymphomas arising in thyroid, stomach, pleura, breast, and brain but not in epithelial malignancies such as testicular and ovarian cancer (unpublished data). The mononucleotide tract in the coding sequence is a mutational hotspot in many kinds of genes, such as transforming growth factor b receptor type II gene , Insulin-like growth factor receptor type II gene (Souza et al., 1996 ), hMSH3, hMSH6 (Malkhosyan et al., 1996 , and BAX gene (Rampino et al., 1997) . The insertion of 1 bp (A) at nucleotide 1095 might be a mutational hotspot in lymphomas of extranodal origin.
In conclusion, the present study provides evidence that the Fas-mediated apoptotic pathway is abrogated in cases of nasal NKTCL. These findings suggest that accumulation of lymphoid cells with Fas mutations provides a basis for development of nasal NKTCL. Figure 3 Cytolytic effect of anti-Fas antibody on WR19L transformant clones was carried out as described previously (Itoh et al., 1991) . The mouse WR19L cell line transfected with plasmid pEF-BOS-EX vector alone and its transformant clones expressing recombinant human Fas protein with (T1102C, A978G, 1095 ins A) or without (wild type) mutations were incubated with various concentrations of anti-Fas antibody at 378C for 16 h. Viable cell counts were determined by the trypan blue exclusion method, and the percentage of viable cells was plotted Figure 2 The 1.1 kb EcoRI-XbaI fragment containing the full length of human Fas cDNA with and without mutations were transferred into a mammalian expression plasmid pEF-BOS-EX (Mizushima and Nagata, 1990) . All mutant constructions were verified by DNA sequencing using dideoxy chain termination. Mouse T cell lymphoma cell lines WR19L (ATCC TIB52) were transfected with the plasmid by electroporation as described previously (Itoh et al., 1991) . After selection with 0.9 mg/ml of G-418, transformants expressing the mutated Fas were identified by Northern blotting and FACS analysis. (a) Total RNA was prepared from WR19L transfected with plasmid pEF-BOS-EX alone (i), transformants expressing the wild type human Fas receptor (ii), 1095 ins A (iii), A978G (iv), T1102C (v), 597 del T (Vi), and 704 del C (Vii). 15 mg of total RNA was electrophoresed on a 1.3% agarose gel containing 6.6% formaldehyde and analysed by Northern hybridization. As a probe, the 1.1 kb EcoRIXbaI fragment containing the full length of human Fas cDNA was labeled with digoxigenin-11 dUTP using a DIG High prime according to the manufacturer's instructions (Roche Molecular Biochemicals, Mannheim, Germany). 28S ribosome RNA served as control. (b) FACS analysis was performed using mouse antihuman Fas monoclonal antibody (CH-11, MBL, Nagoya, Japan) and fluorescein isothiocyanate-conjugated anti-mouse Ig antibody (Capel, Ohio, USA). WR19L transfected with plasmid pEF-BOS-EX alone (i), transformants expressing the wild type human Fas receptor (ii), 1095 ins A (iii), A978G (iv), T1102C (v), 597 del T (Vi), and 704 del C (Vii). The dashed line represents parental WR19L
